{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:25:31Z","timestamp":1790533531203,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jmgm.2021.108028","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:13:39Z","timestamp":1634087619000},"page":"108028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study"],"prefix":"10.1016","volume":"109","author":[{"given":"Tanuja","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunaullah","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemlata","family":"Pundir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2021.108028_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/dyaa033","article-title":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","volume":"49","author":"Peeri","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jmgm.2021.108028_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41551-016-0024","article-title":"An artificial intelligence platform for the multihospital collaborative management of congenital cataracts","volume":"1","author":"Long","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jmgm.2021.108028_bib3","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.jmgm.2021.108028_bib4","doi-asserted-by":"crossref","first-page":"e00819","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2021.108028_bib5","series-title":"Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases","author":"Liu","year":"2020"},{"key":"10.1016\/j.jmgm.2021.108028_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaa033","article-title":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","author":"Peeri","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jmgm.2021.108028_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jmv.25699","article-title":"The first two cases of 2019-nCoV in Italy: where they come from?","volume":"92","author":"Giovanetti","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jmgm.2021.108028_bib8","series-title":"Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)","author":"World Health","year":"2020"},{"key":"10.1016\/j.jmgm.2021.108028_bib9","series-title":"WHO Director-General\u00e2\u20ac\u2122s Remarks at the Media Briefing on 2019-nCoV on 11 February 2020","author":"World Health","year":"2020"},{"key":"10.1016\/j.jmgm.2021.108028_bib10","series-title":"COVID reference. Tradu\u00c3\u00a7\u00c3\u00a3o de Joana Catarina Ferreira da Silva e Sara Mateus Mahomed. Alemanha","author":"Kamps","year":"2020"},{"key":"10.1016\/j.jmgm.2021.108028_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jmv.25729","article-title":"A\u00a0systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option","volume":"92","author":"Yao","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jmgm.2021.108028_bib12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-\u03b12b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","volume":"19","author":"Falzarano","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jmgm.2021.108028_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.jmgm.2021.108028_bib14","series-title":"Meplazumab Treats COVID-19 Pneumonia: an Open-labelled, Concurrent Controlled Add-on Clinical Trial","author":"Bian","year":"2020"},{"key":"10.1016\/j.jmgm.2021.108028_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2021.108028_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jmgm.2021.108028_bib17","first-page":"2020","article-title":"Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study","author":"Tallei","year":"2020","journal-title":"Scientifica"},{"key":"10.1016\/j.jmgm.2021.108028_bib18","first-page":"1","article-title":"COVID-19 vaccines: rapid development, implications, challenges and future prospects","author":"Kashte","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.jmgm.2021.108028_bib19","first-page":"1","article-title":"Strategies in the design of antiviral drugs","author":"De Clercq","year":"2020","journal-title":"Pharmaceut. Sci. Encycl.: Drug Discov. Dev. Manuf."},{"key":"10.1016\/j.jmgm.2021.108028_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1758788","article-title":"Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment","author":"Boopathi","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108028_bib21","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2021.108028_bib22","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain","volume":"21","author":"Ziebuhr","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.jmgm.2021.108028_bib23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/jmv.25985","article-title":"The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections","volume":"92","author":"Musarrat","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jmgm.2021.108028_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-77700-z","article-title":"Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir","volume":"10","author":"Bolcato","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2021.108028_bib25","first-page":"225","article-title":"Herbal plants and plant preparations as remedial approach for viral diseases","volume":"26","author":"Ganjhu","year":"2015","journal-title":"Virus Dis."},{"key":"10.1016\/j.jmgm.2021.108028_bib26","series-title":"Global Harmonisation of Herbal Health Claims","author":"Mahady","year":"2001"},{"key":"10.1016\/j.jmgm.2021.108028_bib27","first-page":"4529","article-title":"In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking","volume":"24","author":"Joshi","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jmgm.2021.108028_bib28","first-page":"3099","article-title":"Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease","volume":"39","author":"Joshi","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108028_bib29","first-page":"1","article-title":"Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2\u00e2\u20ac\u201da molecular dynamic study","author":"Khan","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108028_bib30","first-page":"3213","article-title":"A\u00a0molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2","volume":"39","author":"Islam","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108028_bib31","series-title":"Calcutta International Exhibition, L883-84: Medicinal Products, Superintendent of Government Print","article-title":"Economic products of India exhibited in the economic court","author":"Watt","year":"1883"},{"key":"10.1016\/j.jmgm.2021.108028_bib32","article-title":"Indian medicinal plants","author":"Kirtikar","year":"1998","journal-title":"Indian Med. Plants"},{"key":"10.1016\/j.jmgm.2021.108028_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1076\/1388-0209(200009)3841-AFT254","article-title":"Antimicrobial activity of crude extracts from Berberis asiatica stem bark","volume":"38","author":"Bhandari","year":"2000","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.jmgm.2021.108028_bib34","series-title":"Studies in Medicinal Plants: Part 1-Chemical Constituents of Berberis Asiatica Roxb","author":"Bhakuni","year":"1968"},{"key":"10.1016\/j.jmgm.2021.108028_bib35","series-title":"admetSAR: a Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties","author":"Cheng","year":"2012"},{"key":"10.1016\/j.jmgm.2021.108028_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2007.11.013","article-title":"Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways","volume":"580","author":"Hu","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jmgm.2021.108028_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0367-326X(99)00098-2","article-title":"Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents","volume":"71","author":"Janbaz","year":"2000","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jmgm.2021.108028_bib38","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ptr.5693","article-title":"Berberis vulgaris and berberine: an update review","volume":"30","author":"Imenshahidi","year":"2016","journal-title":"Phytother Res."},{"key":"10.1016\/j.jmgm.2021.108028_bib39","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.foodres.2010.12.038","article-title":"Redox regulation in health and disease\u00e2\u20ac\u201dTherapeutic potential of berberine","volume":"44","author":"Siow","year":"2011","journal-title":"Food Res. Int."},{"key":"10.1016\/j.jmgm.2021.108028_bib40","first-page":"99","article-title":"Traditional Chinese medicine in treatment of metabolic syndrome. Endocrine, metabolic & immune disorders-drug targets (formerly current drug targets-immune","volume":"8","author":"Yin","year":"2008","journal-title":"Endocrine Metabol. Disord."},{"key":"10.1016\/j.jmgm.2021.108028_bib41","unstructured":"Tabeshpour, J., Imenshahidi, M., Hosseinzadeh, H. A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iran. J. Basic Med. Sci.. 20, 557."},{"key":"10.1016\/j.jmgm.2021.108028_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2011.06.009","article-title":"Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control","volume":"410","author":"Popov","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2021.108028_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1590\/S0037-86822004000200016","article-title":"Preliminary assessment of medicinal plants used as antimalarials in the southeastern Venezuelan Amazon","volume":"37","author":"Caraballo","year":"2004","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.jmgm.2021.108028_bib44","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/jm060207o","article-title":"Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease","volume":"49","author":"Lu","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2021.108028_bib45","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/13880200390500768","article-title":"Antibacterial activity and alkaloid content of Berberis thunbergii, Berberis vulgaris and Hydrastis canadensis","volume":"41","author":"Villinski","year":"2003","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.jmgm.2021.108028_bib46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00204-002-0351-9","article-title":"Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver","volume":"76","author":"Hwang","year":"2002","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jmgm.2021.108028_bib47","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.030540597","article-title":"Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5\u00e2\u20ac2-methoxyhydnocarpin, a multidrug pump inhibitor","volume":"97","author":"Stermitz","year":"2000","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.jmgm.2021.108028_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0192-0561(96)00047-1","article-title":"Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids","volume":"18","author":"Ivanovska","year":"1996","journal-title":"Int. J. Immunopharm."},{"key":"10.1016\/j.jmgm.2021.108028_bib49","series-title":"The Treatise on Indian Medicinal Plants","first-page":"33","author":"Chopra","year":"1981"},{"key":"10.1016\/j.jmgm.2021.108028_bib50","first-page":"1","article-title":"Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: computational investigations","author":"Aanouz","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108028_bib51","doi-asserted-by":"crossref","first-page":"104146","DOI":"10.1016\/j.jff.2020.104146","article-title":"Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus","author":"Chojnacka","year":"2020","journal-title":"J.\u00a0Funct. Foods"},{"key":"10.1016\/j.jmgm.2021.108028_bib52","unstructured":"Vardhan, S., Sahoo, S.K. In Silico ADMET and Molecular Docking Study on Searching Potential Inhibitors from Limonoids and Triterpenoids for COVID-19. arXiv preprint arXiv:2005.07955."},{"key":"10.1016\/j.jmgm.2021.108028_bib53","first-page":"1","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.jmgm.2021.108028_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J.\u00a0Mol. Recogn."},{"key":"10.1016\/j.jmgm.2021.108028_bib55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2021.108028_bib56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins: Struct. Funct. Bioinf."},{"key":"10.1016\/j.jmgm.2021.108028_bib57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2021.108028_bib58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2021.108028_bib59","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2021.108028_bib60","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1063\/1.1324708","article-title":"Efficient particle-mesh Ewald based approach to fixed and induced dipolar interactions","volume":"113","author":"Toukmaji","year":"2000","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2021.108028_bib61","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2021.108028_bib62","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J.\u00a0Appl. Phys."},{"key":"10.1016\/j.jmgm.2021.108028_bib63","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.str.2011.03.010","article-title":"Relative solvent accessible surface area predicts protein conformational changes upon binding","volume":"19","author":"Marsh","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2021.108028_bib64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10930-014-9561-2","article-title":"Molecular dynamics simulations and principal component analysis on human laforin mutation W32G and W32G\/K87A","volume":"33","author":"Srikumar","year":"2014","journal-title":"Protein J."},{"key":"10.1016\/j.jmgm.2021.108028_bib65","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2021.108028_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21020222","article-title":"Antimicrobial activity of some novel armed thiophene derivatives and Petra\/Osiris\/Molinspiration (POM) analyses","volume":"21","author":"Mabkhot","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2021.108028_bib67","first-page":"19","article-title":"Pharmacognostic evaluation of the roots of Berberis chitria Lindl","volume":"12","author":"Srivastava","year":"2006","journal-title":"Nat. Prod. Sci."},{"key":"10.1016\/j.jmgm.2021.108028_bib68","doi-asserted-by":"crossref","DOI":"10.1007\/s11101-013-9272-x","article-title":"Phytochemical and pharmacological studies in genus Berberis","volume":"11","author":"Bhardwaj","year":"2012","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.jmgm.2021.108028_bib69","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2021.108028_bib70","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/plants9091244","article-title":"Plants-derived biomolecules as potent antiviral phytomedicines: new insights on ethnobotanical evidences against coronaviruses","volume":"9","author":"Siddiqui","year":"2020","journal-title":"Plants"},{"key":"10.1016\/j.jmgm.2021.108028_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs","author":"Jeon","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2021.108028_bib72","series-title":"MOLECULAR DOCKING STUDY TO IDENTIFY POTENTIAL INHIBITOR OF COVID-19 MAIN PROTEASE ENZYME: AN IN-SILICO APPROACH","author":"Agrawal","year":"2020"},{"key":"10.1016\/j.jmgm.2021.108028_bib73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.indcrop.2016.10.049","article-title":"Microwave-assisted extraction (MAE) conditions using polynomial design for improving antioxidant phytochemicals in Berberis asiatica Roxb. ex DC. leaves","volume":"95","author":"Belwal","year":"2016","journal-title":"Ind. Crop. Prod."},{"key":"10.1016\/j.jmgm.2021.108028_bib74","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/v12020184","article-title":"Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)","volume":"12","author":"Lalani","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2021.108028_bib75","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/19440049.2015.1022885","article-title":"Rapid screening for the adulterants of Berberis aristata using direct analysis in real-time mass spectrometry and principal component analysis for discrimination","volume":"32","author":"Bajpai","year":"2015","journal-title":"Food Addit. Contam. Part A Chem Anal Control Expo Risk Assess"},{"key":"10.1016\/j.jmgm.2021.108028_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/947560","article-title":"Antiviral action of synthetic stigmasterol derivatives on herpes simplex virus replication in nervous cells in\u00a0vitro","volume":"2014","author":"Petrera","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jmgm.2021.108028_bib77","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/JVI.01382-16","article-title":"The antiviral alkaloid berberine reduces chikungunya virus-induced mitogen-activated protein kinase signaling","volume":"90","author":"Varghese","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jmgm.2021.108028_bib78","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.bmcl.2006.12.085","article-title":"Antiviral activity of berberine and related compounds against human cytomegalovirus","volume":"17","author":"Hayashi","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2021.108028_bib79","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00705-020-04706-3","article-title":"Antiviral activity of berberine","volume":"165","author":"Warowicka","year":"2020","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jmgm.2021.108028_bib80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10156-007-0595-7","article-title":"Current challenges in the management of invasive fungal infections","volume":"14","author":"Lai","year":"2008","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.jmgm.2021.108028_bib81","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.3390\/molecules23102475","article-title":"Antiviral mechanism of action of epigallocatechin-3-O-gallate and its fatty acid esters","volume":"23","author":"Kaihatsu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2021.108028_bib82","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/toxins11110656","article-title":"The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens","volume":"11","author":"Thawabteh","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.jmgm.2021.108028_bib83","series-title":"New Look to Phytomedicine","first-page":"273","article-title":"Plant-Derived molecules in managing HIV infection","author":"Trivedi","year":"2019"},{"key":"10.1016\/j.jmgm.2021.108028_bib84","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2021.108028_bib85","first-page":"975","article-title":"Antiviral activity of ellagic acid against envelope proteins from Dengue virus through insilico docking","volume":"6","author":"Bupesh","year":"2014","journal-title":"Int. J. Drug Dev. Res."},{"key":"10.1016\/j.jmgm.2021.108028_bib86","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/v10040152","article-title":"Identification of ellagic acid from plant Rhodiola rosea L. as an anti-Ebola virus entry inhibitor","volume":"10","author":"Cui","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2021.108028_bib87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jff.2017.06.006","article-title":"Antiviral activity of ellagic acid and Annona muricata in cervical HPV related pre-neoplastic lesions: a randomized trial","volume":"35","author":"Le Donne","year":"2017","journal-title":"J.\u00a0Funct. Foods"},{"key":"10.1016\/j.jmgm.2021.108028_bib88","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fmed.2020.00444","article-title":"Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic","volume":"7","author":"Bhuiyan","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.jmgm.2021.108028_bib89","first-page":"337","article-title":"Antioxidants in fruits and roots of Berberis asiatica Rox. ex. DC.: a highly valued Himalayan plant","volume":"31","author":"Andola","year":"2008","journal-title":"Natl. Acad. Sci. Lett."},{"key":"10.1016\/j.jmgm.2021.108028_bib90","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/S0168-8278(14)60582-1","article-title":"P420 gallic acid has antiviral effect against hepatitis C virus (HCV), which is mediated by its antioxidant activity","volume":"60","author":"Salas","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jmgm.2021.108028_bib91","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1590\/S0074-02762008000500005","article-title":"Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate","volume":"103","author":"Kratz","year":"2008","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.jmgm.2021.108028_bib92","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1248\/bpb.31.903","article-title":"Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate","volume":"31","author":"Kratz","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jmgm.2021.108028_bib93","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/13880209.2010.519390","article-title":"Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids","volume":"49","author":"\u00c3\u2013z\u00c3\u00a7elik","year":"2011","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.jmgm.2021.108028_bib94","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3892\/ijmm.2014.1859","article-title":"Inhibition by caffeic acid of the influenza A virus multiplication in\u00a0vitro","volume":"34","author":"Utsunomiya","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jmgm.2021.108028_bib95","first-page":"139","article-title":"Antibacterial and phytochemical studies of bark extract of Berberisasiatica Roxb. Ex. DC. And Myrica esculenta Buch.-Ham ex. D. Don","volume":"17","author":"Gurmachhan","year":"2019","journal-title":"J.\u00a0Plant Res."},{"key":"10.1016\/j.jmgm.2021.108028_bib96","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/molecules17010688","article-title":"The effect of \u00ce2-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients","volume":"17","author":"Sheehan","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2021.108028_bib97","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/AAC.48.7.2595-2598.2004","article-title":"Efficacy of organic acids in hand cleansers for prevention of rhinovirus infections","volume":"48","author":"Turner","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jmgm.2021.108028_bib98","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/00218839.2019.1695715","article-title":"Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds","volume":"59","author":"Kwon","year":"2020","journal-title":"J.\u00a0Apicult. Res."},{"key":"10.1016\/j.jmgm.2021.108028_bib99","series-title":"Antiviral Activity from Medicinal Mushrooms and Their Active Constituents","author":"Stamets","year":"2016"},{"key":"10.1016\/j.jmgm.2021.108028_bib100","series-title":"Multivariate Calibration","author":"Martens","year":"1992"},{"key":"10.1016\/j.jmgm.2021.108028_bib101","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1080\/07391102.2017.1392897","article-title":"Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation","volume":"36","author":"Shukla","year":"2018","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2021.108028_bib102","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tube.2017.11.013","article-title":"Activity loss by H46A mutation in Mycobacterium tuberculosis isocitrate lyase is due to decrease in structural plasticity and collective motions of the active site","volume":"108","author":"Shukla","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jmgm.2021.108028_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-\u00ce21b (MIRACLE trial): study protocol for a randomized controlled trial","volume":"19","author":"Arabi","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.jmgm.2021.108028_bib104","first-page":"1597","article-title":"Potential antiviral drugs for SARS-cov-2 treatment: Preclinical findings and ongoing clinical research","volume":"34","author":"Bimonte","year":"2020","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.jmgm.2021.108028_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2020.06.002","article-title":"Bioactive natural compounds against human coronaviruses: a review and perspective","author":"Xian","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jmgm.2021.108028_bib106","first-page":"1","article-title":"Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19","author":"Joshi","year":"2020","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2021.108028_bib107","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11101-013-9272-x","article-title":"Phytochemical and pharmacological studies in genus Berberis","volume":"11","author":"Bhardwaj","year":"2012","journal-title":"Phytochemistry Rev."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326321001996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326321001996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:09:59Z","timestamp":1761080999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326321001996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":107,"alternative-id":["S1093326321001996"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2021.108028","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Berbamine, Oxyacanthine and Rutin from Berberis asiatica as anti-SARS-CoV-2 compounds: An in silico study","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2021.108028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108028"}}